User profiles for Luc Bertrand

Bertrand Luc

UCLouvain - IREC Institute - WELBIO
Verified email at uclouvain.be
Cited by 12583

Activation of AMP‐activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders

…, S Horman, R Dentin, L Bertrand… - The Journal of …, 2006 - Wiley Online Library
It is now becoming evident that the liver has an important role in the control of whole body
metabolism of energy nutrients. In this review, we focus on recent findings showing that AMP‐…

[HTML][HTML] Metformin: from mechanisms of action to therapies

M Foretz, B Guigas, L Bertrand, M Pollak, B Viollet - Cell metabolism, 2014 - cell.com
Metformin is currently the first-line drug treatment for type 2 diabetes. Besides its glucose-lowering
effect, there is interest in actions of the drug of potential relevance to cardiovascular …

[PDF][PDF] Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia

AS Marsin, L Bertrand, MH Rider, J Deprez… - Current biology, 2000 - cell.com
Background: The role of protein phosphorylation in the Pasteur effect—the phenomenon
whereby anaerobic conditions stimulate glycolysis—has not been addressed. The AMP-…

[PDF][PDF] Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis

…, U Krause, JV Patel, D Vertommen, L Bertrand… - Current biology, 2002 - cell.com
Protein synthesis, in particular peptide-chain elongation, consumes cellular energy. Anoxia
activates AMP-activated protein kinase (AMPK, see [1]), resulting in the inhibition of …

Insulin signalling in the heart

L Bertrand, S Horman, C Beauloye… - Cardiovascular …, 2008 - academic.oup.com
The main role of insulin in the heart under physiological conditions is obviously the regulation
of substrate utilization. Indeed, insulin promotes glucose uptake and its utilization via …

AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure

C Beauloye, L Bertrand, S Horman… - Cardiovascular …, 2011 - academic.oup.com
Heart failure is a progressive muscular disorder leading to a deterioration of the heart
characterized by a contractile dysfunction and a chronic energy deficit. As a consequence, the …

[HTML][HTML] AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation

…, C Beauloye, S Horman, L Bertrand - Nature …, 2018 - nature.com
AMP-activated protein kinase (AMPK) has been shown to inhibit cardiac hypertrophy. Here,
we show that submaximal AMPK activation blocks cardiomyocyte hypertrophy without …

6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis

MH Rider, L Bertrand, D Vertommen… - Biochemical …, 2004 - portlandpress.com
Fru-2,6-P 2 (fructose 2,6-bisphosphate) is a signal molecule that controls glycolysis. Since its
discovery more than 20 years ago, inroads have been made towards the understanding of …

[HTML][HTML] The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase

AS Marsin, C Bouzin, L Bertrand, L Hue - Journal of Biological Chemistry, 2002 - ASBMB
The activation of monocytes involves a stimulation of glycolysis, release of potent inflammatory
mediators, and alterations in gene expression. All of these processes are known to be …

[HTML][HTML] AMPK: Lessons from transgenic and knockout animals

…, F Andreelli, R Ventura-Clapier, L Bertrand - Frontiers in …, 2009 - ncbi.nlm.nih.gov
AMP-activated protein kinase (AMPK), a phylogenetically conserved serine/threonine protein
kinase, has been proposed to function as a ‘fuel gauge’to monitor cellular energy status in …